Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05575375 · ClinicalTrials.gov registry record · NA

Values-Affirmation + Education Intervention Targeting Medication Adherence in Older Adults With Heart Failure

A NA study of Heart Failure, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT05575375 is a NA study of Heart Failure that has completed, run by The Miriam Hospital. The registered enrollment target is 43 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05575375, a NA study of Heart Failure, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

The goals of this study are to determine the (1) feasibility and (2) acceptability of the study procedures through a pilot randomized controlled trial of a values affirmation intervention targeting medication adherence in adults with heart failure enrolled in cardiac rehabilitation relative to usual care.

Conditions Studied

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Values Affirmation + Usual Care

Study Locations (1)

Rhode Island

  • The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2022-09-15
Est. Completion 2025-01-15
Phase NA

Sponsor

The Miriam Hospital

136 total trials

What the Registry Record Tells You About NCT05575375

The ClinicalTrials.gov registry entry for NCT05575375 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT05575375 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05575375 about?

NCT05575375 is a clinical study titled "Values-Affirmation + Education Intervention Targeting Medication Adherence in Older Adults With Heart Failure". The goals of this study are to determine the (1) feasibility and (2) acceptability of the study procedures through a pilot randomized controlled trial of a values affirmation intervention targeting medication adherence in adults with heart failure enrolled in cardiac rehabilitation relative to usual...

What is the current status of trial NCT05575375?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2022-09-15. Estimated completion is 2025-01-15.

What conditions does trial NCT05575375 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT05575375?

The interventions under investigation include: Usual Care (OTHER), Values Affirmation + Usual Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT05575375?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05575375 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.